放射性碘-话题@MedSci

#放射性碘#

29篇内容 | 1117人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1395428, encodeId=560e139542846, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=JCEM：低危分化型甲状腺癌患者应不应该接受放射性碘？, objectType=article, longId=123843, objectId=5097123843b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5097123843b3, replyNumber=0, likeNumber=26, createdTime=2017-12-19, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5097123843b3, moduleTitle=JCEM：低危分化型甲状腺癌患者应不应该接受放射性碘？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5097123843b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395427, encodeId=fd15139542ee1, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=JCEM：二次放射性碘治疗受益几何？, objectType=article, longId=119019, objectId=343011901918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343011901918, replyNumber=0, likeNumber=32, createdTime=2017-11-08, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343011901918, moduleTitle=JCEM：二次放射性碘治疗受益几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=343011901918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395426, encodeId=a5d0139542628, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=Int J Cancer：放射性碘治疗甲状腺癌女性，几乎不影响未来的生育能力, objectType=article, longId=111602, objectId=f9cd11160260, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9cd11160260, replyNumber=0, likeNumber=36, createdTime=2017-09-02, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9cd11160260, moduleTitle=Int J Cancer：放射性碘治疗甲状腺癌女性，几乎不影响未来的生育能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9cd11160260)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395425, encodeId=72c01395425b0, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=J CLIN ONCOL：III期选择性试验中年龄对lenvatinib治疗放射性碘难治性分化型甲状腺癌疗效和安全性的影响, objectType=article, longId=102204, objectId=ee7a1022043f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7a1022043f, replyNumber=0, likeNumber=31, createdTime=2017-06-18, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7a1022043f, moduleTitle=J CLIN ONCOL：III期选择性试验中年龄对lenvatinib治疗放射性碘难治性分化型甲状腺癌疗效和安全性的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7a1022043f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395424, encodeId=d5ad1395424cb, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险, objectType=article, longId=67775, objectId=cd386e7754f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd386e7754f, replyNumber=0, likeNumber=30, createdTime=2016-05-10, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd386e7754f, moduleTitle=Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd386e7754f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395423, encodeId=27061395423f5, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=NEJM：Lenvatinib有望用于放射性碘难治性甲状腺癌治疗, objectType=article, longId=47049, objectId=71304e049a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71304e049a4, replyNumber=0, likeNumber=40, createdTime=2015-02-14, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71304e049a4, moduleTitle=NEJM：Lenvatinib有望用于放射性碘难治性甲状腺癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71304e049a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395422, encodeId=19b0139542207, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=CSMO 2014：林岩松谈分化型甲状腺癌手术后放射性碘-131治疗的规范, objectType=article, longId=37668, objectId=e6203e668d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6203e668d4, replyNumber=0, likeNumber=35, createdTime=2014-07-12, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6203e668d4, moduleTitle=CSMO 2014：林岩松谈分化型甲状腺癌手术后放射性碘-131治疗的规范, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6203e668d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395421, encodeId=259d139542132, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=ASCO 2014：放射性碘治疗无效的晚期分化型甲状腺癌的Ⅲ期研究, objectType=article, longId=35952, objectId=9657359522c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9657359522c, replyNumber=0, likeNumber=35, createdTime=2014-06-06, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9657359522c, moduleTitle=ASCO 2014：放射性碘治疗无效的晚期分化型甲状腺癌的Ⅲ期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9657359522c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1395420, encodeId=45c113954209e, content=<a href='/topic/show?id=504f5e36317' target=_blank style='color:#2F92EE;'>#放射性碘#</a>, objectTitle=Lancet Diab & Endo：放射性碘抵抗分化型甲状腺癌的定义和管理, objectType=article, longId=30982, objectId=34463098274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34463098274, replyNumber=0, likeNumber=42, createdTime=2014-02-23, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34463098274, moduleTitle=Lancet Diab & Endo：放射性碘抵抗分化型甲状腺癌的定义和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34463098274)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

放射性碘

2020-05-29

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

JCEM：低危分化型甲状腺癌患者应不应该接受放射性碘？

2017-12-19

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

JCEM：二次放射性碘治疗受益几何？

2017-11-08

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

Int J Cancer：放射性碘治疗甲状腺癌女性，几乎不影响未来的生育能力

2017-09-02

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

J CLIN ONCOL：III期选择性试验中年龄对lenvatinib治疗放射性碘难治性分化型甲状腺癌疗效和安全性的影响

2017-06-18

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

Thyroid ：放射性碘治疗并不会增加动脉粥样硬化的发生风险

2016-05-10

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

NEJM：Lenvatinib有望用于放射性碘难治性甲状腺癌治疗

2015-02-14

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

CSMO 2014：林岩松谈分化型甲状腺癌手术后放射性碘-131治疗的规范

2014-07-12

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

ASCO 2014：放射性碘治疗无效的晚期分化型甲状腺癌的Ⅲ期研究

2014-06-06

仁医06 (审核中...)

前往app查看评论内容

#放射性碘#

Lancet Diab & Endo：放射性碘抵抗分化型甲状腺癌的定义和管理

2014-02-23

科室
- - 订阅+
  - 更多科室
工具
服务